60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
0.9400
-0.0075 (-0.79%)
Oct 30, 2026, 4:00 PM EST - Market closed
SXTP Revenue
60 Degrees Pharmaceuticals had revenue of $207.90K in the quarter ending June 30, 2026, a decrease of -32.47%. This brings the company's total for the last twelve months to $1.21M, up 23.41% year-over-year. In the year 2025, 60 Degrees Pharmaceuticals had annual revenue of $1.41M with 106.81% growth. That makes 60 Degrees Pharmaceuticals the 43,320th largest company in the world by revenue and 6,014th in the United States.
Revenue (ttm)
$1.21M
Revenue Growth
+23.41%
P/S Ratio
2.72
Revenue / Employee
$404,977
Employees
3
Market Cap
3.31M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.41M | 727.75K | 106.81% |
| Dec 31, 2024 | 681.35K | 427.77K | 168.70% |
| Dec 31, 2023 | 253.57K | -257.64K | -50.40% |
| Dec 31, 2022 | 511.21K | -5.84M | -91.95% |
| Dec 31, 2021 | 6.35M | 3.80M | 149.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
SXTP News
- 4 days ago - 60 Degrees expands vector-borne disease research portfolio with USM - TheFly
- 4 days ago - 60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome - GlobeNewsWire
- 5 days ago - 60 Degrees’ tafenoquine shows improvement in all five babesiosis patients - TheFly
- 5 days ago - 60 Degrees Pharmaceuticals Announces Clinical Improvement and Negative PCR Results in All Completed Expanded Access Babesiosis Study Patients - GlobeNewsWire
- 26 days ago - 60 Degrees Pharmaceuticals Transcript: Study update - Transcripts
- 26 days ago - 60 Degrees Pharmaceuticals Press release: Study update - Filings
- 26 days ago - 60 Degrees Pharmaceuticals to conclude enrollment in tafenoquine study - TheFly
- 26 days ago - 60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA - GlobeNewsWire